Skip To Main Content
Abdou Salam Gueye on Muck Rack

Abdou Salam Gueye

As seen in: ScienceDirect, The Lancet, PeerJ
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Abdou Salam

Contact Abdou Salam, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States

|
By Jean-Marc Boivin, Adidja Amani, Abdou Salam Gueye, Céline Berthélémy
| ScienceDirect Verified
Introduction In response to the COVID-19 pandemic, unprecedented efforts were invested in the successful development, authorization, licensure, and introduction of COVID-19 vaccines. In the United States, the Food and Drug Administration (FDA) is the regulatory authority for vaccines.
Open in Who Shared Issue with article?

Conflicting COVID-19 excess mortality estimates

|
By Matshidiso R Moeti, Lindiwe Makubalo, Abdou Salam Gueye, Thierno Balde
| The Lancet Verified
1 Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. by the COVID-19 Excess Mortality Collaborators estimates more than 18 million COVID-19 deaths globally by the end of 2021—three times those reported.
Open in Who Shared Issue with article?
See all 2 articles